An infant is admitted to the pediatric unit with bronchiolitis caused by respiratory syncytial virus (RSV). Which intervention would the nurse provide for the infant? Select all that apply.

Choice A rationale Instilling saline nose drops helps to thin thick nasal secretions, which is important because infants are obligate nose breathers, and RSV causes significant mucus production that obstructs the nasal passages. This intervention facilitates the subsequent removal of mucus via suctioning, thereby improving the infant's ability to breathe and feed more effectively. Choice B rationale Encouraging feeding is inappropriate for an infant with severe RSV bronchiolitis, as increased respiratory effort and tachypnea increase the risk of aspiration and make sucking difficult. Fluids are typically managed with intravenous therapy or nasogastric tube feeds to conserve energy and ensure adequate hydration, especially if the respiratory rate is greater than 60 breaths per minute. Choice C rationale Limiting fluid intake is incorrect because infants with RSV are at a high risk for dehydration due to increased insensible fluid loss from tachypnea and decreased oral intake due to respiratory distress. Maintaining adequate hydration is a critical component of care, often requiring the administration of intravenous fluids to compensate for these losses. Choice D rationale Maintaining contact and droplet precautions is essential because RSV is primarily transmitted through direct contact with respiratory secretions and large droplets expelled by coughing or sneezing. Strict adherence to these precautions, including wearing gowns, gloves, and a mask, is necessary to prevent the nosocomial spread of the highly contagious virus to other infants and staff. Choice E rationale Nasal suctioning to remove mucus is a crucial intervention because copious, thick nasal secretions are a hallmark of RSV bronchiolitis and severely impair an infant's breathing and feeding. Using a bulb syringe or wall suction before feedings or sleep is vital to clear the airway, reduce respiratory distress, and ensure oxygenation. Choice F rationale Administering intravenous bronchodilators is generally not recommended for RSV bronchiolitis, as the primary pathology is inflammation and obstruction of the small airways (bronchioles) rather than bronchospasm responsive to these medications. The routine use of bronchodilators has not been shown to be consistently effective in this specific viral infection and is typically reserved for those with a history of asthma or clear evidence of wheezing responsive to treatment.